Ablative surgery for Parkinson’s disease: Is there still a role for pallidotomy in the deep brain stimulation era?

[1]  C. Sampaio,et al.  International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease , 2018, Movement disorders : official journal of the Movement Disorder Society.

[2]  W. J. Elias,et al.  The emerging role of transcranial magnetic resonance imaging–guided focused ultrasound in functional neurosurgery , 2017, Movement disorders : official journal of the Movement Disorder Society.

[3]  Dario J. Englot,et al.  An unexpectedly high rate of revisions and removals in deep brain stimulation surgery: Analysis of multiple databases. , 2016, Parkinsonism & related disorders.

[4]  F. Ory-Magne,et al.  Clinical Impact and Cost-Effectiveness of an Education Program for PD Patients: A Randomized Controlled Trial , 2016, PloS one.

[5]  J. Acevedo,et al.  Economic Analysis of Deep Brain Stimulation in Parkinson Disease: Systematic Review of the Literature. , 2016, World neurosurgery.

[6]  K. Hynynen,et al.  A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor. , 2016, The New England journal of medicine.

[7]  A. Gray,et al.  Cost‐utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson's: Economic evaluation alongside the PD SURG trial , 2016, Movement disorders : official journal of the Movement Disorder Society.

[8]  M. Stacy,et al.  Disease-Modifying Drugs in Parkinson’s Disease , 2015, Drugs.

[9]  Yue Chen,et al.  The study on a telemedicine interaction mode for Deep Brain Stimulation postoperative follow-up , 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[10]  P. Krack,et al.  A prospective single-blind study of Gamma Knife thalamotomy for tremor , 2015, Neurology.

[11]  E. Dorsey,et al.  Nursing home and end-of-life care in Parkinson disease , 2015, Neurology.

[12]  P. Kalakoti,et al.  Predictors of unfavorable outcomes following deep brain stimulation for movement disorders and the effect of hospital case volume on outcomes: an analysis of 33, 642 patients across 234 US hospitals using the National (Nationwide) Inpatient Sample from 2002 to 2011. , 2015, Neurosurgical focus.

[13]  Alberto Priori,et al.  Technology for deep brain stimulation at a gallop , 2015, Movement disorders : official journal of the Movement Disorder Society.

[14]  A. Priori,et al.  Web-Based Telemonitoring and Delivery of Caregiver Support for Patients With Parkinson Disease After Deep Brain Stimulation: Protocol , 2015, JMIR research protocols.

[15]  V. Mok,et al.  Cost-effectiveness of subthalmic nucleus deep brain stimulation for the treatment of advanced Parkinson disease in Hong Kong: a prospective study. , 2014, World neurosurgery.

[16]  G. Deuschl,et al.  Myths and facts about the EARLYSTIM study , 2014, Movement disorders : official journal of the Movement Disorder Society.

[17]  P. Pollak,et al.  Subthalamic nucleus‐deep brain stimulation for early motor complications in Parkinson's disease—the EARLYSTIM trial: Early is not always better , 2014, Movement disorders : official journal of the Movement Disorder Society.

[18]  T. Simuni,et al.  Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites , 2014, Movement disorders : official journal of the Movement Disorder Society.

[19]  R. Abbott,et al.  Disparities in deep brain stimulation surgery among insured elders with Parkinson disease , 2014, Neurology.

[20]  D. Lumsden.  Pallidotomy in the 21st century , 2014, Developmental medicine and child neurology.

[21]  Daniel Jeanmonod,et al.  First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease , 2014, Journal of therapeutic ultrasound.

[22]  E. Kluczewska,et al.  MR-Guided Focused Ultrasound: A New Generation Treatment of Parkinson's Disease, Essential Tremor and Neuropathic Pain , 2014 .

[23]  G. Messina,et al.  DBS for Parkinson's disease in a HIV-positive patient: long-term follow-up , 2014, Acta Neurochirurgica.

[24]  V. Jourdain,et al.  Health Economics and Surgical Treatment for Parkinson's Disease in a World Perspective: Results from an International Survey , 2014, Stereotactic and Functional Neurosurgery.

[25]  G. Deuschl,et al.  The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease , 2013, Journal of Neurology.

[26]  Günther Deuschl,et al.  Cost‐effectiveness of deep brain stimulation in patients with Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[27]  G. Deuschl,et al.  Neurostimulation for Parkinson's disease with early motor complications. , 2013, The New England journal of medicine.

[28]  F. Valldeoriola,et al.  Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study , 2013, Journal of medical economics.

[29]  L. Bour,et al.  Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial , 2013, The Lancet Neurology.

[30]  P. Krack,et al.  Long‐term outcomes of surgical therapies for Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[31]  A. Lang,et al.  Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. , 2011, Archives of neurology.

[32]  M. Rizzone,et al.  Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[33]  Regina Katzenschlager,et al.  The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[34]  W. Poewe,et al.  The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[35]  J. Massano,et al.  Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson's Disease in a Patient with HIV Infection: Dual Clinical Benefit , 2011, Case Reports in Neurology.

[36]  F. Horak,et al.  Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. , 2011, Archives of neurology.

[37]  P. Doshi.  Long-Term Surgical and Hardware-Related Complications of Deep Brain Stimulation , 2011, Stereotactic and Functional Neurosurgery.

[38]  K. Bötzel,et al.  Costs of illness and care in Parkinson's Disease: An evaluation in six countries , 2011, European Neuropsychopharmacology.

[39]  W. Oertel,et al.  Costs of Parkinson’s Disease and Antiparkinsonian Pharmacotherapy: An Italian Cohort Study , 2010, Neurodegenerative Diseases.

[40]  Grant D. Huang,et al.  Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. , 2010, The New England journal of medicine.

[41]  Cristina Sampaio,et al.  Late-stage Parkinson’s disease: the Barcelona and Lisbon cohort , 2010, Journal of Neurology.

[42]  Kai Zhang,et al.  Infections and Hardware Salvage after Deep Brain Stimulation Surgery: A Single-Center Study and Review of the Literature , 2010, Stereotactic and Functional Neurosurgery.

[43]  D. Hellwig,et al.  Skin complications in deep brain stimulation for Parkinson’s disease: frequency, time course, and risk factors , 2010, Acta Neurochirurgica.

[44]  K. Ashkan,et al.  Deep brain stimulation for Parkinson's disease when HIV coexists , 2009, Movement disorders : official journal of the Movement Disorder Society.

[45]  J. Jankovic,et al.  Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. , 2009, Surgical neurology.

[46]  J. Obeso,et al.  Therapeutic efficacy of unilateral subthalamotomy in Parkinson’s disease: results in 89 patients followed for up to 36 months , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[47]  S. Karamürsel,et al.  Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson's disease , 2009, British journal of neurosurgery.

[48]  J. Speelman,et al.  Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression , 2008, Movement disorders : official journal of the Movement Disorder Society.

[49]  R. Gross.  What happened to posteroventral pallidotomy for Parkinson’s disease and dystonia? , 2008, Neurotherapeutics.

[50]  Michael S. Okun,et al.  Clinical Cases where Lesion Therapy Was Chosen over Deep Brain Stimulation , 2008, Stereotactic and Functional Neurosurgery.

[51]  Karl A. Sillay,et al.  Deep brain stimulator hardware-related infections: incidence and management in a large series. , 2008, Neurosurgery.

[52]  F. J. Carod-Artal,et al.  Disability and use of healthcare resources in Brazilian patients with Parkinson's disease , 2008, Disability and rehabilitation.

[53]  G. Friehs,et al.  Stereotactic radiosurgery for functional disorders. , 2007, Neurosurgical focus.

[54]  B. Kall,et al.  Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease. , 2007, Journal of neurosurgery.

[55]  L. Findley,et al.  The economic impact of Parkinson's disease. , 2007, Parkinsonism & related disorders.

[56]  A. Shumway-cook,et al.  Staged unilateral versus bilateral subthalamic nucleus stimulator implantation in Parkinson disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[57]  J. Jankovic,et al.  Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis , 2007, Acta Neurochirurgica.

[58]  G. Deuschl,et al.  Effect of medical and surgical interventions on health‐related quality of life in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[59]  P. Starr,et al.  Effects of unilateral subthalamic and pallidal deep brain stimulation on fine motor functions in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[60]  R. Esselink,et al.  Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in Parkinson’s disease: one year follow-up of a randomised observer-blind multi centre trial , 2006, Acta Neurochirurgica.

[61]  A. Velasco,et al.  Comparative Evaluation of the Effects of Unilateral Lesion versus Electrical Stimulation of the Globus Pallidus Internus in Advanced Parkinson’s Disease , 2006, Stereotactic and Functional Neurosurgery.

[62]  P. Caramelli,et al.  Parkinsonism and Parkinson's disease in the elderly: A community‐based survey in Brazil (the Bambuí study) , 2006, Movement disorders : official journal of the Movement Disorder Society.

[63]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[64]  J. Voges,et al.  Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery—experiences from a single centre , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[65]  A. Samii,et al.  Deep brain stimulation in a patient on immunosuppressive therapy after renal transplant. , 2005, Parkinsonism & related disorders.

[66]  P. Hogarth,et al.  Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. , 2005, Archives of neurology.

[67]  B. Schmand,et al.  Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD , 2005, Journal of Neurology.

[68]  T. Aziz,et al.  Cost analysis of unilateral and bilateral pallidotomy for Parkinson's disease , 2004, Journal of clinical neuroscience.

[69]  R. Iacono,et al.  Health related quality of life in patients with Parkinson’s disease two years following posteroventral pallidotomy , 2004, Acta Neurochirurgica.

[70]  Marwan I. Hariz,et al.  Are Complications Less Common in Deep Brain Stimulation than in Ablative Procedures for Movement Disorders? , 2004, Stereotactic and Functional Neurosurgery.

[71]  J. Gracies,et al.  Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study. , 2004, Journal of neurosurgery.

[72]  Michael S Okun,et al.  Lesion therapy for Parkinson's disease and other movement disorders: Update and controversies , 2004, Movement disorders : official journal of the Movement Disorder Society.

[73]  R. D. de Haan,et al.  Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD , 2004, Neurology.

[74]  Jeremy Holmes,et al.  Direct economic impact of Parkinson's disease: A research survey in the United Kingdom , 2003, Movement disorders : official journal of the Movement Disorder Society.

[75]  Klaus Mewes,et al.  Randomized trial of pallidotomy versus medical therapy for Parkinson's disease , 2003, Annals of neurology.

[76]  Li Qinchuan,et al.  Analysis of Complications of Radiofrequency Pallidotomy , 2003, Neurosurgery.

[77]  G. Hall,et al.  Parkinson's disease and anaesthesia. , 2002, British journal of anaesthesia.

[78]  Aviva Abosch,et al.  Long-term Hardware-related Complications of Deep Brain Stimulation , 2002, Neurosurgery.

[79]  M. Merello,et al.  Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation , 2001, Journal of neurology, neurosurgery, and psychiatry.

[80]  M. Hariz,et al.  A 10-year follow-up review of patients who underwent Leksell's posteroventral pallidotomy for Parkinson disease. , 2001, Journal of neurosurgery.

[81]  A. Lang,et al.  Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. , 2000, The New England journal of medicine.

[82]  A. Tröster,et al.  Health-Related Quality of Life in Parkinson's Disease after Pallidotomy and Deep Brain Stimulation , 2000, Brain and Cognition.

[83]  B. Schmand,et al.  Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial , 1999, The Lancet.

[84]  F. Tiberghien,et al.  Protease inhibitors enhance levodopa effects in Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.

[85]  M. Staal.  Textbook of Stereotactic and Functional Neurosurgery , 1999, Spinal Cord.

[86]  M. Merello,et al.  Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum: A prospective randomized comparison , 1999, Movement disorders : official journal of the Movement Disorder Society.

[87]  R B Wallace,et al.  The health burdens of Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.

[88]  A. Lozano,et al.  A brief history of pallidotomy. , 1997, Neurosurgery.

[89]  K Whetten-Goldstein,et al.  The Burden of Parkinson's Disease on Society, Family, and the Individual , 1997, Journal of the American Geriatrics Society.

[90]  A. Benabid,et al.  Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. , 1996, Journal of neurosurgery.

[91]  L. Leksell,et al.  TREATMENT OF PARKINSONISM BY STEREOTACTIC THERMOLESIONS IN THE PALLIDAL REGION. A clinical evaluation of 81 cases. , 1960, Acta psychiatrica Scandinavica.

[92]  I. Cooper,et al.  Intracerebral injection of procaine into the globus pallidus in hyperkinetic disorders. , 1954, Science.

[93]  P. Bucy,et al.  TREMOR: PHYSIOLOGIC MECHANISM AND ABOLITION BY SURGICAL MEANS , 1939 .

[94]  Thomas Rossel,et al.  Clinical/Scientific Notes , 2015 .

[95]  T. Di Paolo,et al.  Subthalamotomy in the treatment of Parkinson's disease: clinical aspects and mechanisms of action. , 2014, Journal of neurosurgery.

[96]  M. Hariz,et al.  Therapeutic stimulation versus ablation. , 2013, Handbook of clinical neurology.

[97]  P. Pollak.  Deep brain stimulation for Parkinson's disease - patient selection. , 2013, Handbook of clinical neurology.

[98]  Katunina Ea,et al.  [Epidemiology of Parkinson's disease]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[99]  K. Bötzel,et al.  Costs of Illness in a Russian Cohort of Patients with Parkinson’s Disease , 2012, PharmacoEconomics.

[100]  W. Oertel,et al.  Cost of illness and its predictors for Parkinson’s disease in Germany , 2012, PharmacoEconomics.

[101]  K. Bötzel,et al.  Costs of Parkinson's disease in eastern Europe: a Czech cohort study. , 2010, Parkinsonism & related disorders.

[102]  M. Ranjbar,et al.  Health-Related Quality of Life in Patients , 2008 .

[103]  A. Lozano,et al.  Pallidotomy for parkinson disease: a review of contemporary literature. , 2001, Journal of neurosurgery.

[104]  D. J. Cole,et al.  Surgical Intervention and Anesthetic Management of the Patient with Parkinson's Disease , 1996, International anesthesiology clinics.

[105]  M Loyo-Varela,et al.  Pallidotomy in Parkinson's disease. , 1996, Neurosurgery.

[106]  M. Hariz,et al.  Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. , 1992, Journal of neurosurgery.

[107]  M. Hariz,et al.  Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. , 1992, Stereotactic and functional neurosurgery.

[108]  I. S. Cooper.  Ligation of the anterior choroidal artery for involuntary movements-parkinsonism , 1953, The Psychiatric quarterly.